查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470905

止血剂市场：按类型、配方和应用分类 - 2024-2030 年全球预测

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年止血剂市场规模为32.3亿美元，预计2024年将达34.2亿美元，2030年将达47.5亿美元，复合年增长率为5.65%。

止血剂是各种医疗设备和产品，旨在控制、预防和止血手术和创伤过程中的出血。这些医疗设备在控制出血、促进组织正常癒合、同时降低併发症风险方面发挥重要作用。止血剂在许多外科专业中都有应用，包括心血管外科、一般外科、整形外科、神经外科、妇科外科和牙科外科。与人口老化相关的慢性病的增加增加了对需要有效止血解决方案的手术的需求，导致各种止血剂的使用增加。此外，人们对微创手术的日益青睐，以及政府机构和医疗机构为改善手术基础设施而增加的投资，也增加了止血剂的使用。与开发创新产品相关的高昂研发成本以及止血剂污染的高风险正在阻碍市场成长。市场供应商不断开拓生物相容性止血剂，提供有效的出血控制，同时最大限度地减少副作用，预计将创造市场成长机会。

主要市场统计
基准年[2023] 32.3亿美元
预测年份 [2024] 34.2亿美元
预测年份 [2030] 47.5亿美元
复合年增长率（%） 5.65%

由于减少型出血的有效性提高，合併止血剂的使用增加

胶原蛋白止血剂源自精製的胶原蛋白，以其优异的生物相容性和透过引发血小板凝集促进血栓形成的能力而闻名。这些止血剂是涉及软组织和脆弱结构的手术的首选，例如神经外科手术和眼科手术。复方止血剂由两种或多种活性剂组成，它们协同作用以增强止血功效。一般来说，产品结合了胶原蛋白、明胶和凝血酶等止血剂的优点。由于复合止血剂在减少复杂手术过程中出血併发症的有效性不断提高，因此对复合止血剂的需求不断增加。氧化再生纤维素止血剂是由植物来源的纤维素经过氧化再生过程製成的。它具有抗菌特性，透过在血管和周围组织之间形成物理屏障来有效控制出血。基于 ORC 的止血剂常用于牙科、胃肠道和妇科手术。凝血酶止血剂含有人类或牛凝血酶作为活性成分，可活化凝血连锁并迅速形成血栓。它对于控制传统技术无效或不切实际的出血特别有用，例如心血管手术或器官移植。胶原蛋白止血剂具有高度生物相容性，通常是精细手术的首选。联合止血剂由于协同效应而更加有效。明胶止血剂因其在危急情况下快速凝固血液的能力而受到重视。基于 ORC 的止血剂具有抗菌特性，并为控制出血创建物理屏障，而基于凝血酶的止血剂则激活凝血连锁并快速形成血栓。

粉末状止血剂在製定的外科手术过程中控制和预防出血的潜力越来越大。

基质止血剂和凝胶止血剂是生物相容性、可吸收的材料，可促进血栓快速形成。当在手术期间难以施加直接压力时，例如在微创手术中，这是优选的。粉状止血剂吸收出血组织中的液体并促进血小板聚集。易于使用，使其适用于各种外科手术，包括一般外科、整形外科、心血管外科和神经外科。止血片和止血垫片是柔性的生物可吸收材料，使其高度适应不规则的伤口表面。用于需要覆盖大面积且缝合困难的手术。海绵止血剂是一种高吸水性材料，易于成型为各种形状，适用于不规则的创腔。常用于牙科、口腔外科、神经外科、心血管外科等。基质和凝胶止血剂可在难以到达的区域快速形成凝块，而粉末止血剂则易于在外科专业中使用。海绵止血剂也为不规则的创腔提供优异的吸收性和成型性。

应用止血剂在心血管手术中的重要角色是防止出血，确保手术效果。

在心血管手术中，有大量的血液流经动脉和静脉，需要高效率的止血材料来防止出血。止血剂由于其快速作用和实现有效止血的能力而在这些手术中被广泛优选。在一般外科手术中，止血剂的使用在伤口处理和确保盲肠和疝气修復等手术期间尽量减少出血方面发挥重要作用。妇科手术通常需要在子宫切除术和子宫肌瘤切除术等精细手术中仔细控制出血。止血剂有效地减少粘连，同时在此类手术过程中提供充分的止血。止血剂是专门为满足这些需求而设计的，同时保留神经结构。关节重建和骨折融合术等整形外科手术需要强大的止血器来切割緻密的骨骼和结缔组织。在包括植皮和皮瓣重组的重组手术中，失血控制对于手术的成功至关重要。在这些情况下，首选止血剂，因为它们与多种组织相容，并且可以有效密封大伤口。与其他应用相比，心血管手术对先进止血剂的需求很高。

区域洞察

先进医疗设施的不断增加和外科手术数量的增加，特别是在美国、加拿大和巴西，正在推动美洲止血剂市场的成长。根据美国整形外科医师协会的数据，2022 年总合进行了 1,017,003 例需要使用止血剂的重组手术。加拿大、杜拜、新加坡、日本和英国医疗旅游的新兴趋势正在扩大微创手术的数量，并为止血剂市场形成一个平台。根据医疗旅游指数调查 (MTA)，加拿大是首选旅游目的地之一，吸引了约 1,400 万名来自其他国家的美国人。医疗设备正在加强欧洲市场。由于医疗保健成本不断上升以及政府努力实现医疗保健基础设施现代化，中东和非洲地区提供了充满希望的成长机会。在沙乌地阿拉伯、阿拉伯联合大公国和南非等国家，随着外科手术数量的增加，对有效止血解决方案的需求正在迅速增加。此外，由于政府增加了扩大国内医疗设备製造的资金以及人们对微创手术的认识不断增强，印度、澳洲、中国和日本正在推动亚太地区的市场成长。

FPNV定位矩阵

FPNV定位矩阵对于评估止血剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对止血器市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.止血器市场的市场规模与预测是多少？

2.在止血剂市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.止血剂市场的技术趋势和法规结构是什么？

4.止血器市场主要厂商的市场占有率是多少？

5. 进入止血剂市场的适当形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行增加了手术介入的需要
      • 微创手术的成长趋势
    • 抑制因素
      • 产品回收数量增加
    • 机会
      • 基于生物聚合物的一次性止血剂的兴起
      • 奈米技术整合止血剂，使其更有效率、更有针对性
    • 任务
      • 使用止血工具和试剂相关的感染和交叉污染的风险
  • 市场区隔分析
    • 类型：由于减少出血的效果改善，扩大了合併止血剂的使用
    • 处方：粉末止血剂在手术介入期间控制和预防出血的潜力不断增长
    • 应用：止血剂在心血管手术中预防失血、保证手术成功的重要作用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章止血剂市场：按类型

  • 胶原胶原蛋白止血剂
  • 组合止血器
  • 明胶止血剂
  • 氧化再生纤维素系止血剂
  • 凝血酶止血剂

第七章 止血剂市场：依配方分类

  • 基质和凝胶止血剂
  • 粉末止血剂
  • 片材和垫片止血剂
  • 海绵止血剂

第八章止血剂市场：依应用分类

  • 心血管外科
  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科
  • 重组手术

第九章美洲止血剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太止血剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲止血剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Teleflex 获得 FDA核准在心臟手术中扩大 QuikClot Control+ 止血装置的使用
    • 百特推出可吸收止血粉“PERCLOT”
    • Artivion 的 Parcrot 获得 FDA核准并开始转移到 Baxter
    • Olympus Europe SE & Co. KG 扩大与 Endoclot 的合作关係，推出止血剂
    • Darling Ingredients 完成对巴西明胶和胶原蛋白製造商 Gelnex 的收购
    • 用于减少严重手术出血的几丁聚醣止血剂已获得 FDA 批准
    • AdvaMedica 宣布 FDA 批准 Ax-Surgi 手术止血器
    • Medcura 的 LifeGel 可吸收手术止血材料获得突破性器械称号
    • MedtronicNekuPowder 内视镜止血系统获得美国FDA 批准
    • Hemostasis LLC 完成对 Fiagon Medical Technologies 的收购
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-961BA04A2E36

[192 Pages Report] The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.

The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.23 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.65%

Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding

Collagen-based hemostats are derived from purified collagen; they are known for their excellent biocompatibility and ability to accelerate clot formation by initiating platelet aggregation. These hemostats are often preferred in surgeries involving soft tissues and delicate structures, such as neurosurgery and ophthalmic surgery. Combination hemostats consist of two or more active agents that work synergistically to enhance hemostatic efficacy. They typically combine the benefits of hemostats, such as collagen-based, gelatin-based, and thrombin-based products. The demand for combination hemostats is growing due to their increased effectiveness in minimizing bleeding complications during complex surgical procedures. Oxidized regenerated cellulose-based hemostats are made from plant-derived cellulose that undergoes oxidation and regeneration processes. They possess antimicrobial properties and effectively control bleeding by creating a physical barrier between blood vessels and surrounding tissues. ORC-based hemostats are often used in dental surgeries, gastrointestinal surgeries, and gynecological procedures. Thrombin-based hemostats contain human or bovine thrombin as their active ingredient, which activates the coagulation cascade, resulting in rapid clot formation. They are particularly useful in controlling bleeding where traditional techniques may be ineffective or impractical, such as cardiovascular surgeries or organ transplantations. The collagen-based hemostats provide excellent biocompatibility and are often preferred for delicate surgeries. Combination hemostats offer increased effectiveness due to their synergistic properties. Gelatin-based hemostats are valued for their rapid blood clotting ability in critical situations. ORC-based hemostats exhibit antimicrobial properties and create a physical barrier for bleeding control, while thrombin-based hemostats activate the coagulation cascade for rapid clot formation.

Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention

Matrix and gel hemostats are biocompatible, absorbable materials that facilitate rapid clot formation. They are preferred in situations where the application of direct pressure during surgery is difficult, such as in minimally invasive procedures. Powder hemostats work by absorbing fluid from bleeding tissue and enhancing platelet aggregation. Their ease of application makes them suitable for various surgical specialties, including general, orthopedic, cardiovascular, and neurosurgery. Sheet and pad hemostats are flexible bioabsorbable materials, allowing for better conformity to irregular wound surfaces. They are utilized in surgeries where larger areas need to be covered, and suturing is challenging. Sponge hemostats are highly absorbent materials easily molded into various shapes, making them suitable for irregular wound cavities. They are commonly used in dental and oral surgeries, as well as neurosurgery and cardiovascular surgery. Matrix & gel hemostats provide rapid clot formation in hard-to-reach areas, whereas powder hemostats offer easy application across surgical specialties. Sheet & pad hemostats conform to irregular wound surfaces covering larger areas; then, sponge hemostats provide excellent absorbency and moldability for irregular wound cavities.

Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes

Cardiovascular surgeries involve high blood flow, arteries, and veins, often requiring efficient hemostatic solutions to prevent excessive bleeding. Hemostats are widely preferred in these procedures due to their rapid action and ability to achieve effective hemostasis. In general surgery, the use of hemostats plays a significant role in wound management and ensuring minimum blood loss during procedures such as appendectomy and hernia repair. Gynecological surgeries often require meticulous control of bleeding during delicate procedures such as hysterectomy and myomectomy. Hemostats have effectively minimized adhesions while providing adequate hemostasis during these surgeries. Hemostats are specifically designed to address this need while preserving neural structures. Orthopedic surgeries, including joint replacements and fracture fixation, require robust hemostatic agents as they involve cutting through dense bone and connective tissues. In reconstructive surgery, which includes skin grafting and flap reconstruction, managing blood loss becomes critical for successful outcomes. Hemostatic agents are preferred in these cases due to their adaptability across different tissues and ability to seal large wounds effectively. Compared to other applications, cardiovascular surgeries show a higher need-based preference for advanced hemostatic agents.

Regional Insights

The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Collagen-Based Hemostats
    • Combination Hemostats
    • Gelatin-Based Hemostats
    • Oxidized Regenerated Cellulose-Based Hemostats
    • Thrombin-Based Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Reconstructive Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hemostats Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats Market?

3. What are the technology trends and regulatory frameworks in the Hemostats Market?

4. What is the market share of the leading vendors in the Hemostats Market?

5. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
    • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
    • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
    • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
    • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
    • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
    • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HEMOSTATS MARKET DYNAMICS
  • FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 298. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023